Current endoscopic visualization techniques often struggle to differentiate between healthy and cancerous tissue, leading to missed lesions or unnecessary biopsies. Standard white-light endoscopy lacks the sensitivity to detect subtle changes in tissue composition and vascularity that indicate early-stage malignancies.

OptoMedic develops medical fluorescence navigation endoscopes that enhance visualization during endoscopic procedures. Their systems utilize advanced optical technology to improve the detection and characterization of cancerous tissue. The endoscopes employ fluorescence imaging to highlight subtle differences between healthy and diseased tissue, providing surgeons with real-time guidance during procedures. This technology aims to improve cancer screening and endoscopic monitoring, enabling more precise diagnoses and targeted interventions.

Real-time fluorescence imaging to differentiate between healthy and cancerous tissue

Enhanced visualization of tissue composition and vascularity

Integration with existing endoscopic platforms

Improved cancer screening and endoscopic monitoring capabilities

The primary users are medical professionals, including surgeons, gastroenterologists, and pulmonologists, who perform endoscopic procedures for cancer screening and diagnosis.